02.04.2017 – Our new article on Real-world effectiveness of antipsychotic treatments among patients with schizophrenia and affective symptoms has been published on European Psychiatry.
In an evaluation of 22 specific antipsychotic treatments against the most frequently used antipsychotic quetiapine, it was found that the lowest rehospitalization risks were observed during the treatment periods of olanzapine long-acting injection, risperidone LAI and clozapine, and the worst outcome observed with the use of periciazine and no antipsychotic use.
For more detailed description of the study methods and results, you can click the link below.
J. Tiihonen, M. Lähteenvuo, F. Hoti, P. Vattulainen, H. Taipale, A. Tanskanen. Real-world effectiveness of antipsychotic treatments among patients with schizophrenia and affective symptoms.– Read abstract.